Late-Life Depression

Blazer D . Depression. In: Beers MH Berkow R , eds. Merck manual of geriatrics.Whitehouse Station, NJ:Merck and Co., Inc.; 2000:310–22.

Blazer D Swartz M Woodbury M Depressive symptoms and depressive diagnoses in a community population. Use of a new procedure for analysis of psychiatric classification. Arch Gen Psychiatry 1988;45:1078–84.

NIH consensus conference. Diagnosis and treatment of depression in late life. JAMA 1992;268:1018–24.

Lebowitz BD Pearson JL Schneider LS Diagnosis and treatment of depression in late life. Consensus statement update. JAMA 1997;278:1186–90.

Older adults: depression and suicide facts (2003). National Institute of Mental Health website. Available: www.nimh.nih.gov/publicat/elderlydepsuicide.cfm (accessed January 5, 2005.).

Bruce ML McNamara R . Psychiatric status among the homebound elderly: an epidemiologic perspective. J Am Geriatr Soc 1992;40:561–6.

Sheline YI Sanghavi M Mintun MA Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999;19:5034–43.

Stahl S . Essential psychopharmacology: neuroscientific basis and practical applications.New York, NY:Cambridge University Press; 2000.

Duman RS Heninger GR Nestler EJ . A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54:597–606.

Clinical Practice Guideline Number 5: Depression in Primary Care, 1: Detection and Diagnosis.Rockville, MD:Agency for Health Care Policy and Research, US Department of Health and Human Services; 1993. AHCPR Publication No. 93–0550.

Depression in special circumstances: the elderly. Canadian Network for Mood and Anxiety Treatments website. Available: www.canmat.org/depress/index.html (accessed December 8, 2004.).

Sable JA Dunn LB Zisook S . Late-life depression. How to identify its symptoms and provide effective treatment. Geriatrics 2002;57:18–9, 22–3, 26.

Alexopoulos GS Katz IR Reynolds CF Ross R . Depression in older adults: a guide for patients and families.White Plains, NY:Expert Knowledge Systems and Comprehensive NeuroScience Inc.; 2001.

Yesavage JA Brink TL Rose TL Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983;17:37–49.

Allen N Ames D Ashby D A brief sensitive screening instrument for depression in late life. Age Ageing 1994;23:213–9.

Alexopoulos GS Abrams RC Young RC Cornell scale for depression in dementia. Biol Psychiatry 1988;23:271–84.

Doraiswamy PM . Contemporary management of comorbid anxiety and depression in geriatric patients. J Clin Psychiatry 2001;62(suppl 12):30–5.

Mulsant BH Rosen J Thornton JE A prospective naturalistic study of electroconvulsive therapy in late-life depression. J Geriatr Psychiatry Neurol 1991;4:3–13.

Thorpe L Whitney DK Kutcher SP Clinical guidelines for the treatment of depressive disorders. VI. Special populations. Can J Psychiatry 2001;46(suppl 1):63S–76S.

Thomas L Mulsant BH Solano FX Response speed and rate of remission in primary and specialty care of elderly patients with depression. Am J Geriatr Psychiatry 2002;10:583–91.

Stahl SM . Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Biol Psychiatry 2000;48:894–901.

De Boer T . The pharmacologic profile of mirtazapine. J Clin Psychiatry 1996;57(suppl 4):19–25.

Fawcett J Barkin RL . Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J Affect Disord 1998;51:267–85.

Schatzberg AF Kremer C Rodrigues HE , Mirtazapine vs Paroxetine Study Group. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Am J Geriatr Psychiatry 2002;10:541–50.

Thase ME Entsuah AR Rudolph RL . Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234–41.

Smith D Dempster C Glanville J Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiatry 2002;180:396–404.

Fitton A Faulds D Goa KL . Moclobemide: a review of its pharmacological properties and therapeutic use in depressive illness. Drugs 1992;43:561–96.

Amrein R Stabl M Henauer S Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview. Can J Psychiatry 1997;42:1043–50.

Wellbutrin [product information].Research Triangle Park, NC:Glaxo Wellcome Inc; 2002.

Hebel SK Killion KH Burnham TH , eds. Drug Facts and Comparisons 2003 Pocket Version.St. Louis, MO:Facts and Comparisons; 2002.

McLeod PJ Huang AR Tamblyn RM Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997;156:385–91.

Roose SP Laghrissi-Thode F Kennedy JS Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287–91.

Ray WA Griffin MR Schaffner W Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987;316:363–9.

St. John's Wort. Natural Medicines Comprehensive Database. Available: www.naturaldatabase.com (accessed December 8, 2004.).

Philipp M Kohnen R Hiller KO . Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks. BMJ 1999;319:1534–8.

Coppen A Whybrow PC Noguera R The comparative antidepressant value of l-tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch Gen Psychiatry 1972;26:234–41.

Poldinger W Calanchini B Schwarz W . A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine. Psychopathology 1991;24:53–81.

Nakajima T Kudo Y Kaneko Z . Clinical evaluation of 5-hydroxy-l-tryptophan as an antidepressant drug. Folia Psychiatr Neurol Jpn 1978;32:223–30.

Reesal R . Antidepressant discontinuation syndrome. Can J Diagnosis 1999;Nov:9–125.

Fava M . Augmentation and combination strategies in treatment-resistant depression. J Clin Psychiatry 2001:62(suppl 18):4–11.

Georgotas A McRue RE . The additional benefit of extending an antidepressant trial past seven weeks in the depressed elderly. Int J Geriatr Psychiatry 1989;4:191–5.

Feinberg M Dinwiddie J Wells BG . Depression in the elderly. J Am Soc Consult Pharm 1997;12(Suppl 4):12–1 to 10.

Hirschfeld RMA . Guidelines for the long-term treatment of depression. J Clin Psychiatry 1994;55(suppl 12):60–9.

Penninx BW Geerlings SW Deeg DJ Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry 1999;56:889–95.

Schulz R Beach SR Ives DG . Association between depression and mortality in older adults, the cardiovascular health study. Arch Intern Med 2000;160:1761–8.